{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:05:17Z","timestamp":1753891517779,"version":"3.41.2"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>This study aimed to evaluate the therapeutic efficacy and safety of intravitreal conbercept in patients with chronic central serous chorioretinopathy (cCSC) complicated by occult choroidal neovascularization (CNV), and to explore its potential in improving visual function and various ophthalmic parameters.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This retrospective, longitudinal, comparative study included 50 patients diagnosed with cCSC and occult CNV. Patients underwent intravitreal conbercept injections and were monitored over a six-month period. Comprehensive ophthalmic evaluation included best-corrected visual acuity (BCVA), central macular thickness (CMT), subretinal fluid (SRF) status, subfoveal choroidal thickness (SFCT), and optical coherence tomography angiography (OCTA). OCTA parameters such as foveal avascular zone (FAZ) area and CNV lesion characteristics were analyzed pre- and post-treatment. Patients were categorized based on changes in CNV lesion size to identify prognostic factors influencing treatment response.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Significant improvements were observed in mean BCVA from baseline (0.78\u202f\u00b1\u202f0.50 vs. 0.32\u202f\u00b1\u202f0.31, <jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.01) in all 50 eyes of the patients, except for one eye. Additionally, there were significant improvements in CMT, SRF status, SFCT, FAZ area, and CNV lesion size post-treatment (<jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.05). Pearson correlation analysis indicated a positive correlation between baseline BCVA and CMT (<jats:italic>r<\/jats:italic>\u202f=\u202f0.3615, <jats:italic>p<\/jats:italic>\u202f=\u202f0.0116). Changes in BCVA post-treatment correlated with alterations in CMT, SRF diameter, and CNV lesion size. Patients with a favorable treatment response had significantly lower baseline CMT (312.17\u202f\u00b1\u202f57.39 vs. 428.86\u202f\u00b1\u202f114.54, <jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.05) and CNV vessel diameter (17.46\u202f\u00b1\u202f2.72 vs. 24.84\u202f\u00b1\u202f4.02, <jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.01) compared to those with unfavorable responses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Intravitreal conbercept injection was found to be safe and effective in improving BCVA and various ophthalmic parameters in patients with cCSC complicated by occult CNV, with no significant adverse effects observed during the study period. Baseline CMT, SRF diameter, CNV lesion size, and mean CNV vessel diameter were identified as valuable indicators for assessing treatment response and prognosis. These findings provide important insights for the clinical management and prognostic evaluation of cCSC patients with occult CNV, highlighting the utility of multimodal imaging in assessing treatment outcomes.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2025.1550543","type":"journal-article","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T06:10:49Z","timestamp":1742883049000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Intravitreal conbercept for chronic central serous chorioretinopathy with occult CNV: a retrospective clinical study based on multimodal ophthalmic imaging"],"prefix":"10.3389","volume":"12","author":[{"given":"Suyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhipeng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keran","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"101236","DOI":"10.1016\/j.preteyeres.2024.101236","article-title":"Central serous chorioretinopathy: an evidence-based treatment guideline","volume":"101","author":"Feenstra","year":"2024","journal-title":"Prog Retin Eye Res"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1146\/annurev-vision-102122-102907","article-title":"Central serous Chorioretinopathy: epidemiology, genetics and clinical features","volume":"10","author":"Khan","year":"2024","journal-title":"Annu Rev Vision Sci"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"100865","DOI":"10.1016\/j.preteyeres.2020.100865","article-title":"Central serous chorioretinopathy: an update on risk factors, pathophysiology and imaging modalities","volume":"79","author":"Kaye","year":"2020","journal-title":"Prog Retin Eye Res"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ajo.2018.06.009","article-title":"Clinical features of central serous Chorioretinopathy with type 1 choroidal neovascularization","volume":"193","author":"Shiragami","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.3390\/diagnostics13172792","article-title":"Three-year follow-up detecting choroidal neovascularization with swept source optical coherence tomography angiography (SS-OCTA) after successful half-Fluence photodynamic therapy for chronic central serous Chorioretinopathy","volume":"13","author":"Esteban-Flor\u00eda","year":"2023","journal-title":"Diagnostics"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e0238072","DOI":"10.1371\/journal.pone.0238072","article-title":"Sensitivity and specificity of high-resolution wide field fundus imaging for detecting neovascular age-related macular degeneration","volume":"15","author":"Maruyama-Inoue","year":"2020","journal-title":"PLoS One"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1016\/j.drudis.2022.04.009","article-title":"Multimodal molecular imaging in drug discovery and development","volume":"27","author":"Vermeulen","year":"2022","journal-title":"Drug Discov Today"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"25158414211002400","DOI":"10.1177\/25158414211002400","article-title":"Advances in multimodal imaging in ophthalmology","volume":"13","author":"Ringel","year":"2021","journal-title":"Therap Adv Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"354","DOI":"10.4103\/0974-9233.142279","article-title":"Multimodal imaging for the diagnosis of an atypical case of central serous chorioretinopathy","volume":"21","author":"Kahloun","year":"2014","journal-title":"Middle East Afr J Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.3390\/life13061407","article-title":"Central serous Chorioretinopathy by autofluorescence, enface and SLO\u2013Retromode imaging","volume":"13","author":"Savastano","year":"2023","journal-title":"Life"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3390\/ph13110359","article-title":"Central serous Chorioretinopathy: treatment with laser","volume":"13","author":"Battaglia Parodi","year":"2020","journal-title":"Pharmaceuticals"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1007\/s00417-023-06315-7","article-title":"The effect of nondamaging subthreshold laser therapy in patients with chronic central serous chorioretinopathy","volume":"262","author":"Lee","year":"2024","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1007\/s00417-021-05256-3","article-title":"Subthreshold laser therapy with a standardized macular treatment pattern in chronic central serous chorioretinopathy","volume":"259","author":"Schworm","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"100770","DOI":"10.1016\/j.preteyeres.2019.07.003","article-title":"Central serous chorioretinopathy: towards an evidence-based treatment guideline","volume":"73","author":"Van Rijssen","year":"2019","journal-title":"Prog Retin Eye Res"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.joco.2019.06.006","article-title":"Intravitreal bevacizumab administration for the treatment of chronic central serous chorioretinopathy","volume":"31","author":"Alishiri","year":"2019","journal-title":"J Curr Ophthalmol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1097\/IAE.0000000000003615","article-title":"Multimodal imaging features and treatment responses of choroidal neovascularization secondary to central serous CHORIORETINOPATHY","volume":"42","author":"Jeong","year":"2022","journal-title":"Retina"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ajo.2018.08.026","article-title":"Conbercept for treatment of Neovascular age-related macular degeneration: results of the randomized phase 3 PHOENIX study","volume":"197","author":"Liu","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"750132","DOI":"10.3389\/fmed.2021.750132","article-title":"Cost-effectiveness of Conbercept vs. Ranibizumab for age-related macular degeneration, diabetic macular edema, and pathological myopia: population-based cohort study and Markov model","volume":"8","author":"Cui","year":"2021","journal-title":"Front Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"8010","DOI":"10.1038\/s41598-020-65000-5","article-title":"Clinical outcomes of 1 + PRN and 3 + Q3M regimens of intravitreal conbercept injection for exudative age-related macular degeneration","volume":"10","author":"Gao","year":"2020","journal-title":"Sci Rep"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"11997","DOI":"10.1038\/s41598-024-62536-8","article-title":"Comparative study on the efficacy of Conbercept and Aflibercept in the treatment of neovascular age-related macular degeneration","volume":"14","author":"Xie","year":"2024","journal-title":"Sci Rep"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"335","DOI":"10.17219\/acem\/168808","article-title":"Clinical efficacy of conbercept injection on neovascular age-related macular degeneration under different levels of inflammation","volume":"33","author":"Zhang","year":"2023","journal-title":"Adv Clin Exp Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"CR51\u2013CR57","DOI":"10.12659\/MSM.882455","article-title":"Indocyanine green angiography in chronic central serous chorioretinopathy","volume":"18","author":"Gajdzik-Gajdecka","year":"2012","journal-title":"Med Sci Monit"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1055\/a-0834-6118","article-title":"Choroidal neovascularisation complicating chronic central serous Chorioretinopathy: the discovery rate on multimodal imaging","volume":"236","author":"Romdhane","year":"2019","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"6994","DOI":"10.3390\/jcm11236994","article-title":"Characteristics and classification of choroidal caverns in patients with various retinal and Chorioretinal diseases","volume":"11","author":"Guo","year":"2022","journal-title":"J Clin Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1358\/dot.2020.56.5.3137164","article-title":"An update on conbercept to treat wet age-related maculardegeneration","volume":"56","author":"Ferro Desideri","year":"2020","journal-title":"Drugs Today"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1159\/000535930","article-title":"Clinical landscape of central serous Chorioretinopathy in Germany: Retina.net CSC registry report number 1","volume":"247","author":"Lange","year":"2024","journal-title":"Ophthalmologica"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1136\/bjophthalmol-2019-314625","article-title":"Predictors of treatment response to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy for choroidal neovascularisation secondary to chronic central serous chorioretinopathy","volume":"104","author":"Romdhane","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1038\/s41433-019-0511-2","article-title":"Early response to the treatment of choroidal neovascularization complicating central serous chorioretinopathy: a OCT-angiography study","volume":"33","author":"Sacconi","year":"2019","journal-title":"Eye"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.2147\/OPTH.S135461","article-title":"Photodynamic therapy combined with antivascular endothelial growth factor treatment for recalcitrant chronic central serous chorioretinopathy","volume":"11","author":"Asahi","year":"2017","journal-title":"Clin Ophthalmol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e57642","DOI":"10.1371\/journal.pone.0057642","article-title":"Structural characterization of a recombinant fusion protein by instrumental analysis and molecular modeling","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS One"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12886-017-0485-4","article-title":"Correlation between short- and long-term effects of intravitreal ranibizumab therapy on macular edema after branch retinal vein occlusion: a prospective observational study","volume":"17","author":"Minami","year":"2017","journal-title":"BMC Ophthalmol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/08164622.2021.2016022","article-title":"One-year follow-up of choroidal and macular thickness in acute non-treated central serous chorioretinopathy","volume":"106","author":"Ordu\u00f1a-Azcona","year":"2023","journal-title":"Clin Exp Optom"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1007\/s00417-017-3720-z","article-title":"Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea","volume":"255","author":"Van Dijk","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40662-023-00349-y","article-title":"Central serous chorioretinopathy: updates in the pathogenesis, diagnosis and therapeutic strategies","volume":"10","author":"Zhang","year":"2023","journal-title":"Eye Vision"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/IAE.0000000000002791","article-title":"Clinical features of flat irregular pigment epithelial detachment associated with choroidal neovascularization in chronic central serous CHORIORETINOPATHY","volume":"41","author":"Guo","year":"2021","journal-title":"Retina"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/00006982-200202000-00004","article-title":"Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous","volume":"22","author":"Loo","year":"2002","journal-title":"Chorioretinopathy"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"101604","DOI":"10.1016\/j.pdpdt.2019.101604","article-title":"Choriocapillary vascular density in central serous chorioretinopathy complicated by choroidal neovascularization","volume":"29","author":"Cennamo","year":"2020","journal-title":"Photodiagn Photodyn Ther"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"5924","DOI":"10.1167\/iovs.18-25517","article-title":"Association of Upregulated Angiogenic Cytokines with Choroidal Abnormalities in chronic central serous Chorioretinopathy","volume":"59","author":"Terao","year":"2018","journal-title":"Investig Opthalmol Visual Sci"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ajo.2015.04.012","article-title":"Optical coherence tomography angiography signs of vascular Abnormalization with antiangiogenic therapy for choroidal neovascularization","volume":"160","author":"Spaide","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1007\/s10792-021-01768-3","article-title":"The morphology of choroidal neovascularization in chronic central serous chorioretinopathy presenting with flat, irregular pigment epithelium detachment","volume":"41","author":"Azzolini","year":"2021","journal-title":"Int Ophthalmol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3390\/jpm12050839","article-title":"Associations between Choriocapillaris flow on optical coherence tomography angiography and cardiovascular risk profiles of patients with acute myocardial infarction","volume":"12","author":"Kim","year":"2022","journal-title":"J Person Med"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.oret.2017.01.003","article-title":"OCT angiography of treatment-Na\u00efve quiescent choroidal neovascularization in Pachychoroid Neovasculopathy","volume":"1","author":"Carnevali","year":"2017","journal-title":"Ophthalmol Retina"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"e0271543","DOI":"10.1371\/journal.pone.0271543","article-title":"Association between retinal sensitivity and the presence of quiescent choroidal neovascularization in pachychoroid diseases","volume":"17","author":"Ozawa","year":"2022","journal-title":"PLoS One"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"821565","DOI":"10.3389\/fmed.2022.821565","article-title":"A few-shot learning-based retinal vessel segmentation method for assisting in the central serous Chorioretinopathy laser surgery","volume":"9","author":"Xu","year":"2022","journal-title":"Front Med"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"104056","DOI":"10.1016\/j.compbiomed.2020.104056","article-title":"Weakly supervised detection of central serous chorioretinopathy based on local binary patterns and discrete wavelet transform","volume":"127","author":"Xu","year":"2020","journal-title":"Comput Biol Med"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.oret.2018.02.002","article-title":"Natural history of treatment-Na\u00efve quiescent choroidal neovascularization in age-related macular degeneration using OCT angiography","volume":"2","author":"Carnevali","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1097\/IAE.0000000000001964","article-title":"Vascular remodeling of choroidal neovascularization after anti\u2013vascular endothelial growth factor therapy visualized on optical coherence tomography angiography","volume":"39","author":"Miere","year":"2019","journal-title":"Retina"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1550543\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T06:10:52Z","timestamp":1742883052000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1550543\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":47,"alternative-id":["10.3389\/fmed.2025.1550543"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1550543","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2025,3,25]]},"article-number":"1550543"}}